Projections of Global Mortality and Burden of Disease from 2002 to 2030

  title={Projections of Global Mortality and Burden of Disease from 2002 to 2030},
  author={Colin D. Mathers and Dejan Lon{\vc}ar},
  journal={PLoS Medicine},
Background Global and regional projections of mortality and burden of disease by cause for the years 2000, 2010, and 2030 were published by Murray and Lopez in 1996 as part of the Global Burden of Disease project. These projections, which are based on 1990 data, continue to be widely quoted, although they are substantially outdated; in particular, they substantially underestimated the spread of HIV/AIDS. To address the widespread demand for information on likely future trends in global health… 

Measuring the global burden of disease and epidemiological transitions: 2002–2030

Projections to 2030 indicate that, although these major vascular diseases will remain leading causes of global disease burden, with HIV/AIDS the leading cause, diarrhoeal diseases and lower respiratory infections will be outranked by COPD, in part reflecting the projected increases in death and disability from tobacco use.

Aging, Transition, and Estimating the Global Burden of Disease

The results show that the GBD mortality model did not accurately estimate survival at older ages as developed countries transitioned in the twentieth century and may be similarly flawed in developing countries now undergoing transition.

Projections of global health outcomes from 2005 to 2060 using the International Futures integrated forecasting model.

Long-term, integrated health forecasting helps to understand the links between health and other markers of human progress and offers powerful insight into key points of leverage for future improvements.

History of global burden of disease assessment at the World Health Organization

  • C. Mathers
  • Medicine, Political Science
    Archives of Public Health
  • 2020
WHO work on global burden of disease has positioned it to be the lead agency for monitoring many of the UN Sustainable Development Goals and current moves to use IHME analyses raises a number of issues for WHO and for Member States.

Projection of the Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years in Korea for 2030

It is demonstrated that NCDs will continue to account for the majority of the disease burden in Korea in the future.

Cardiovascular disease burden in acute public hospitals in Ireland: estimates for 2021 and 2031

The results reflect the aging of the Irish population and the expected increases in case numbers will pose significant burden on acute public hospitals and the cost of providing care.

Methodological Challenges in Estimating Trends and Burden of Cardiovascular Disease in Sub-Saharan Africa

A case is made for optimal but cost-effective surveillance and prevention of CVD in SSA through appraisal of the current CVD statistics and literature through the origins and evolution of GBD metrics and the methodological limitations inherent in the current GBD statistics.



The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 -- Global Burden of Disease and Risk Factors

The editors of the second edition of Disease Control Priorities in Developing Countries (DCP2) decided to use the Version 3 GBD estimates for Chapter 3 The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001.

The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020.

This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors" and use historical trends in main determinants to project mortality and disease burden forward to 2020.

Measuring the Global Burden of Disease and Risk Factors, 1990–2001

This chapter begins with a brief history of the work on burden of disease, including a discussion of the nature and origins of the disability-adjusted life year (DALY) as a measure of disease burden, and summarizes the methods and findings of the 2001 GBD study.

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant, and given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

Global burden of disease and risk factors

Global Burden of Disease and Risk Factors examines the comparative importance of diseases, injuries, and risk factors; it incorporates a range of new data sources to develop consistent estimates of incidence, prevalence, severity and duration, and mortality for 136 major diseases and injuries.

Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates

Sensitivity analysis can be used to examine the effects of social values that have been incorporated into the design of the disability–adjusted life year (DALY), where age weight is the most controversial value built into the DALY.

Estimates of global mortality attributable to smoking in 2000

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

If recent trends in diabetes prevalence rates continue linearly over the next 50 years, future changes in the size and demographic characteristics of the U.S. population will lead to dramatic increases in the number of Americans with diagnosed diabetes.